Anti‑cytokine therapy for psoriasis – not only TNF‑α blockers. Overview of reports on the effectiveness of therapy with IL‑12/IL‑23 and T and B lymphocyte inhibitors

Anti‑cytokine therapy for psoriasis – not only TNF‑α blockers. Overview of reports on the effectiveness of therapy with IL‑12/IL‑23 and T and B lymphocyte inhibitors

TNF‑α inhibitors – infliximab, etanercept and adalimumab – can be used in the treatment of psoriasis vulgaris and psoriatic arthritis, along with other inhibitors of proinflammatory cytokines, such as interleukin‑12 (IL‑12) and IL‑23.This paper presents the results of research on the use of biologic...

Full description

Bibliographic Details
Main Authors: Dominika Wcisło‑Dziadecka, Martyna Zbiciak, Ligia Brzezińska‑Wcisło, Urszula Mazurek
Format: Article
Language:English
Published: Index Copernicus International S.A. 2016-12-01
Series:Postępy Higieny i Medycyny Doświadczalnej
Subjects:
Psoriasis
psoriatic arthritis
therapy
biological drugs
Online Access:http://phmd.pl/gicid/01.3001.0009.6898

Similar Items

Similar Items